Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

08/08/2025 07:38

Aug 8 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Dec 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.41                2.86             6.30     
                 (-15.7 pct)         (+14.9 pct)      (+0.1 pct)  
  Operating        46 mln              482 mln          215 mln   
                 (-90.3 pct)                          (-65.9 pct) 
  Recurring        20 mln              528 mln          200 mln   
                 (-96.1 pct)                          (-70.9 pct) 
  Net              279 mln             764 mln          300 mln   
                 (-63.4 pct)                          (-66.6 pct) 
  EPS             5.57 yen            15.24 yen        5.98 yen   
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T